Comments on National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)  

作　　者：Yong Yang 

机构地区：[1]Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Urology,Peking University Cancer Hospital&Institute,Beijing 100142,China

出　　处：《Chinese Journal of Cancer Research》2022年第5期456-457,共2页中国癌症研究（英文版）

摘　　要：National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)(1) was organized by the National Health Commission of the People’s Republic of China, led by the Cancer Hospital of the Chinese Academy of Medical Sciences, and jointly compiled by well-known experts across China. On the basis of the 2018version, the 2022 version of the guideline not only absorbs the updated content of the latest international guidelines.

关 键 词：DIAGNOSIS CANCER TREATMENT 

分 类 号：R737.25[医药卫生—肿瘤]